glp-1 drugs shortage FDA says of drug tirzepatide is over FDA says that the GLP-1
Description
An increasing number of patients treated with novel antidiabetic drugs, including glucagon-like-peptide-1 receptor agonists (GLP-1RA), dual glucose-dependent insulinotropic polypeptide receptor agonists and sodium-glucose cotransporter-2 (SGLT2) inhibitors, are presenting in the perioperative...

Alabamas attorney general recently filed a lawsuit against a medical spa alleging that it administered unapproved versions of GLP-1 weight loss drugs to patients without informing them that the formulations were not authorized by the FDA

But now

A key feature of the consensus is its endorsement of shared decision-making, taking into account patient goals, preferences, access, and affordability